Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Payables: 2011-2025

Historic Payables for Lifecore Biomedical (LFCR) over the last 15 years, with May 2025 value amounting to $8.2 million.

  • Lifecore Biomedical's Payables fell 49.68% to $8.2 million in Q2 2025 from the same period last year, while for May 2025 it was $48.6 million, marking a year-over-year decrease of 27.17%. This contributed to the annual value of $8.2 million for FY2025, which is 49.68% down from last year.
  • As of FY2025, Lifecore Biomedical's Payables stood at $8.2 million, which was down 49.68% from $16.3 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Payables registered a high of $22.1 million during FY2023, and its lowest value of $8.2 million during FY2025.
  • Moreover, its 3-year median value for Payables was $16.3 million (2024), whereas its average is $15.6 million.
  • In the last 5 years, Lifecore Biomedical's Payables plummeted by 77.50% in 2021 and then skyrocketed by 70.61% in 2023.
  • Lifecore Biomedical's Payables (Yearly) stood at $11.6 million in 2021, then increased by 11.44% to $13.0 million in 2022, then spiked by 70.61% to $22.1 million in 2023, then dropped by 26.08% to $16.3 million in 2024, then plummeted by 49.68% to $8.2 million in 2025.